AI/ML Regulatory Support for Medical Devices & IVD
From AI/ML innovation to compliance – without compromise
Compliance support for AI/ML Medical Devices
Compliance support for AI/ML Medical Devices
Artificial intelligence (AI) and machine learning (ML) are redefining what medical devices can do; however, with transformative capability comes a uniquely complex regulatory burden – one that is highly challenging for manufacturers to navigate alone, especially given the high fluidity and unknowns surrounding regulatory frameworks for a rapidly evolving technology.
Today’s AI/ML-enabled device manufacturers entering the EU market face a dual compliance challenge: meeting existing obligations under EU MDR/IVDR , while simultaneously preparing for new obligations introduced by the EU AI Act. This involves implementing robust processes covering design and development, data governance, risk management, human oversight, and transparency, extending throughout the entire device life cycle from pre-market development to post-market monitoring. Getting this right from the start is not just a regulatory necessity – it is a strategic advantage that accelerates market entry and builds a sustainable foundation for AI/ML device lifecycle management.
We've supported over 20 manufacturers through the full complexity of AI/ML compliance — from GMLP implementation and QMS adaptation to EU AI Act readiness and technical documentation for notified body submissions. We don't treat these as separate workstreams. Our approach builds a cohesive compliance architecture that integrates AI-specific requirements directly into your existing device lifecycle process, so that regulatory readiness evolves in step with your product, reducing time-to-market and supporting sustainable compliance across the full device lifecycle.
How Qserve can help
Training on MDR/IVDR/AI Act expectations on AI/ML-enabled devices
Gain knowledge, from our practical experience, on MDR/IVDR/AIA expectations on manufacturers intending to put AI/ML-enabled devices on the European market.
AI-focused GAP assessment: MDR/IVDR, Good Machine Learning Practices and EU AI Act
We perform gap assessments to assist you in identifying compliance GAPs and developing mitigation strategies and actions.
Clinical Evaluation support for MDR/IVDR
We can support designing and executing clinical/performance evaluation tailored for AI/ML-enabled medical devices for MDR/IVDR compliance.
AI Technical Documentation support for MDR/IVDR and EU AI Act compliance
Expert support in preparing and structuring AI/ML-specific technical documentation in compliance with the requirements from EU MDR/IVDR and AI Act, incorporating GMLP considerations.
Regulatory Strategy Support on EU AI Act for manufacturers with existing AI/ML-enabled devices on the market
Strategic regulatory guidance helps manufacturers of AI/ML-enabled medical devices already on the EU market assess their obligations under the EU AI Act and define a structured, risk-based compliance roadmap ahead of applicable transition deadlines.
Training on AI/ML impact on QMS processes
Targeted training for quality and regulatory teams on the practical implications of AI/ML-enabled devices for QMS processes, covering required adaptations under ISO 13485, EU MDR/IVDR, AI Act, and GMLP across design controls, risk management, data governance, clinical/performance evaluation, and post-market surveillance.
Enabling regulatory readiness to evolve
1. Dual-framework expertise One of the very few consultancies with hands-on expertise spanning EU MDR/IVDR and the EU AI Act — so you don't need multiple partners to cover the full compliance picture.
2. Proven track record Practical experience supporting over 20 AI/ML-enabled device manufacturers in the EU and US, across a range of device types and risk classifications.
3. Integrated compliance architecture We don't bolt AI Act requirements onto existing MDR/IVDR processes — we build a single, cohesive compliance framework that eliminates duplication and works across your entire device lifecycle.
4. Navigating regulatory uncertainty Deep familiarity with evolving regulations and guidance means we help you make defensible compliance decisions today, even where frameworks are still maturing.
5. Time-to-market as a strategic outcome Regulatory readiness that evolves in step with your product, turning compliance from a bottleneck into a competitive advantage.
Enabling regulatory readiness to evolve
1. Dual-framework expertise One of the very few consultancies with hands-on expertise spanning EU MDR/IVDR and the EU AI Act — so you don't need multiple partners to cover the full compliance picture.
2. Proven track record Practical experience supporting over 20 AI/ML-enabled device manufacturers in the EU and US, across a range of device types and risk classifications.
3. Integrated compliance architecture We don't bolt AI Act requirements onto existing MDR/IVDR processes — we build a single, cohesive compliance framework that eliminates duplication and works across your entire device lifecycle.
4. Navigating regulatory uncertainty Deep familiarity with evolving regulations and guidance means we help you make defensible compliance decisions today, even where frameworks are still maturing.
5. Time-to-market as a strategic outcome Regulatory readiness that evolves in step with your product, turning compliance from a bottleneck into a competitive advantage.
AI Compliance Strategy
AI Compliance Strategy
Without a proactive AI compliance strategy, companies risk rework, audit findings, or delayed market entry when requirements from MDR, IVDR, and the AI Act converge unexpectedly. The lack of integration between your quality system and AI processes can lead to inefficiencies and significant regulatory risk.
Our approach integrates AI/ML requirements into your QMS from the start, aligning design documentation, performance evidence, and lifecycle management with both medical device and AI-specific rules. This ensures your AI-enabled device is built and maintained in a way that’s inspection-ready, compliant, and ready to scale.
Relevant Blogs
We provide a high-level survey of AI-specific cybersecurity threats relevant to MDSW. Read the full blog!
We're proud to announce that our AI start-up client relios.vision GmbH obtained the CE mark for its medical device software (MDSW) in record time.
While the EU AI Act defines what must be done to bring compliant AI to the European market, the standards determine how those requirements must be met.